Importantly, the enhanced cell proliferation or migration observed in the K450/451R mutant was blocked by EHMT1 inhibition (Fig. 4I and J), suggesting that catalytic activity of EHMT1 is required for the unmethylated form to promote prostate cancer progression. Here, EHMT1 is linked to prostate carcinoma.